Chung-Her Jenh Selected Research

SCH 546738

1/2012

A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chung-Her Jenh Research Topics

Disease

3	Inflammation (Inflammations) 08/2011 - 01/2010
1	Experimental Arthritis 01/2012
1	Rheumatoid Arthritis 01/2012
1	Autoimmune Diseases (Autoimmune Disease) 01/2012
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2012
1	Multiple Sclerosis 01/2012
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2012
1	Respiratory Hypersensitivity 08/2011
1	Hypersensitivity (Allergy) 08/2011
1	Hyperinsulinism (Hyperinsulinemia) 03/2011
1	Body Weight (Weight, Body) 03/2011
1	Non-alcoholic Fatty Liver Disease 03/2011
1	Fatty Liver 03/2011
1	Obesity 01/2010
1	Astrocytoma (Pilocytic Astrocytoma) 05/2005

Drug/Important Bio-Agent (IBA)

2	ChemokinesIBA 08/2011 - 05/2005
1	SCH 546738IBA 01/2012
1	CXCR3 ReceptorsIBA 01/2012
1	Chemokine ReceptorsIBA 08/2011
1	AllergensIBA 08/2011
1	EnzymesIBA 03/2011
1	Alanine Transaminase (SGPT)IBA 03/2011
1	Messenger RNA (mRNA)IBA 03/2011
1	Rosiglitazone (Avandia)FDA Link 01/2010
1	CholesterolIBA 01/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2005
1	Interleukin-8 (Interleukin 8)IBA 05/2005
1	Uridine Diphosphate (UDP)IBA 05/2005

Therapy/Procedure

1	Therapeutics 01/2012
1	Heart Transplantation (Grafting, Heart) 01/2012